Israeli, Canadian Companies Team Up to Improve Rare-Disease Diagnosis
Israeli firm Geneyx Genomex and Canadian EpiSign Inc. are collaborating to enhance rare disease diagnosis by combining genetic and gene expression analysis.
Israeli firm Geneyx Genomex and Canadian EpiSign Inc. are collaborating to enhance rare disease diagnosis by combining genetic and gene expression analysis.